Skip to main content
. 2015 Nov 2;6(35):36955–36964. doi: 10.18632/oncotarget.6271

Table 3. Association of genetic risk score and SAD risk in the testing set.

# of subjects (SAD/Controls) Mean GRS Median GRS
Sample set SAD Controls SAD Controls P value AUC
GRS based on 6 SNPs 227/378 2.48 1.15 0.85 0.55 <0.001 0.63
 APOE ε4 carriers 93/81 4.57 2.47 2.51 1.69 0.003 0.64
 APOE ε4 non-carriers 134/297 1.03 0.79 0.53 0.47 0.101 0.55
Modified GRS based on 3 non APOE-related SNPs 227/378 1.02 0.91 0.87 0.87 0.002 0.58
 APOE ε4 carriers 93/81 1.01 0.92 0.87 0.87 0.187 0.56
 APOE ε4 non-carriers 134/297 1.02 0.91 0.87 0.87 0.006 0.58

Abbreviation: SAD, sporadic Alzheimer's disease; GRS, genetic risk score